Copyright © 2005, The European Society of Cardiology
Long-term echocardiographic follow-up of a patient with primary pulmonary hypertension receiving iloprost inhalations
aDepartment of Cardiology, Rikshospitalet, 0027 Oslo
bDepartment of Internal Medicine, Ålesund Hospital, 6026 Ålesund
Received 27 January 2004; received in revised form 4 May 2004; accepted after revision 15 June 2004.
* Corresponding author. Hjertemedisinsk Avdeling, Rikshospitalet, 0027 Oslo, Norway. Tel.: +47 23074146. eirik.pettersen{at}rikshospitalet.no
| Abstract |
|---|
Iloprost inhalation has recently emerged as an alternative therapy for severe primary pulmonary hypertension. In the studies documenting the effect of iloprost inhalation therapy, hemodynamic variables have been measured invasively. We have followed a patient with primary pulmonary hypertension receiving iloprost inhalation therapy for 5 years using echocardiography to monitor changes in pulmonary artery pressure and right ventricular function. Echocardiography was also used to evaluate the initial response to iloprost inhalation therapy. This case illustrates the feasibility and utility of echocardiography in the testing and follow-up of iloprost inhalation therapy in patients with pulmonary hypertension.
Keywords: Primary pulmonary hypertension; Echocardiography; Iloprost